Back

Ejection fraction as challenge in cardio-oncology: metastatic RCC in a patient with severe cardiotoxic cardiomyopathy and end stage renal failure in remission after DLBCL and R-CHOP therapy

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: From the clinic to Florence: experiences at the frontline of cardio-oncology (2) Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Andreas Spannbauer

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Cancer-induced marantic endocarditis with severe valvular destruction successfully treated with aortic valve replacement and transcatheter mitral repair in a young patient with lung adenocarcinoma
Doctor L. Hauptmann (Vienna, AT)
Slides Video
Presentation thumbnail
Chemotherapy-related cardiotoxicity beyond cancer treatment: A hidden threat
Doctor D. Arcese (Florence, IT)
Slides Video
Presentation thumbnail
Utilizing CMR parametric mapping to diagnose and monitor progressive LVH in acute lymphoblastic leukemia relapse treated with CAR-T therapy
Doctor M. Jung (Seoul, KR)
Slides Video
Presentation thumbnail
Simultaneous transcatheter pulmonary and tricuspid valve replacement in carcinoid heart disease.
Professor J. Bergler-Klein (Vienna, AT)
Slides Video
Presentation thumbnail
Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities
Miss A. Strijdhorst (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
From the clinic to Florence: experiences at the frontline of cardio-oncology (2)

The Event

Event poster

ESC Cardio-Oncology 2025

20 June - 21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources